Significant Ownership of Inscobee Inc.

Signature - Title
/s/ You In Soo - You In Soo, Chief Executive Officer
Location
Seoul, Korea, Republic of
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Inscobee Inc..

Follow Filing Activity

Follow Inscobee Inc. and return when a new Schedule 13D/G filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sponsored

Significant Ownership of Inscobee Inc.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
APUS Apimeds Pharmaceuticals US, Inc. Common Stock 34% $5,870,600 4,316,618 0% Apimeds Inc. 25 Mar 2026

Schedules 13D/G Reported by Inscobee Inc.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.